Club Drugs and Novel Psychoactive Substances
GPTKB entity
Statements (45)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug category
|
| gptkbp:associatedWith |
gptkb:law
euphoria increased sociability hallucinations recreational use risk of overdose psychoactive effects |
| gptkbp:canIncludeConsumptionOf |
smoking
injection oral ingestion snorting |
| gptkbp:emergedIn |
early 21st century
late 20th century |
| https://www.w3.org/2000/01/rdf-schema#label |
Club Drugs and Novel Psychoactive Substances
|
| gptkbp:includes |
gptkb:ecstasy
gptkb:ketamine gptkb:MDMA gptkb:NBOMe_compounds gptkb:mephedrone gptkb:piperazines LSD amphetamine GHB synthetic cannabinoids synthetic cathinones |
| gptkbp:monitors |
gptkb:United_Nations_Office_on_Drugs_and_Crime
gptkb:European_Monitoring_Centre_for_Drugs_and_Drug_Addiction |
| gptkbp:regulates |
gptkb:Controlled_Substances_Act_(USA)
gptkb:Misuse_of_Drugs_Act_(UK) international drug conventions |
| gptkbp:riskFactor |
addiction
mental health issues physical health complications |
| gptkbp:sometimesMarketedAs |
designer drugs
research chemicals legal highs |
| gptkbp:subjectOf |
law enforcement action
public health concern harm reduction campaigns |
| gptkbp:usedIn |
music festivals
nightclubs raves |
| gptkbp:bfsParent |
gptkb:Dr_Owen_Bowden-Jones
|
| gptkbp:bfsLayer |
7
|